Proteomic analysis of plasma from Portuguese patients with familial amyotrophic lateral sclerosis

References

• Bruijn LI, Miller TM, Cleveland DW. Unravelling the mechanisms involved in motor neuron degeneration in ALS. Annu Rev Neurosci. 2004; 27: 723–49
   PubMed Web of Science ®Google Scholar
• Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993; 362: 59–62
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000; 1: 293–9
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Swash M. Conventional neurophysiology in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis2nd edn, RSM Brown, P Pasinelli. Informa UK Ltd. 2006; 105–23
   Google Scholar
• Nirmalananthan N, Greensmith L. Amyotrophic lateral sclerosis: recent advances and future therapies. Curr Opin Neurol. 2005; 18: 712–9
   PubMed Web of Science ®Google Scholar
• Sheta EA, Appel SH, Goldknopf IL. 2D gel blood serum biomarkers reveal differential clinical proteomics of the neurodegenerative diseases. Expert Rev Proteomics. 2006; 3: 45–62
   PubMed Web of Science ®Google Scholar
• Bowser R, Cudkowicz M, Kaddurah-Daouk R. Biomarkers for amyotrophic lateral sclerosis. Expert Rev Mol Diagn. 2006; 6: 387–98
   PubMed Web of Science ®Google Scholar
• Sanchez J, Hochstrasser D. Preparation and solubilization of body fluids for 2-D. 2-D Proteome Analysis Protocols (Methods in Molecular Biology), AJ Link. Humana Press Inc, Totowa 1999; 87–103
   Google Scholar
• Candiano G, Bruschi M, Musante L, Santucci L, Ghiggeri GM, Carnemolla B, et al. 2 Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis. 2004; 25: 1327–33
   PubMed Web of Science ®Google Scholar
• Wang W, Sun J, Nimtz M, Deckwer WD, Zeng AP. Protein identification from two-dimensional gel electrophoresis analysis of Klebsiella pneumoniae by combined use of mass spectrometry data and raw genome sequences. Proteome Sci. 2003; 1: 6
   PubMedGoogle Scholar
• Palma A, de Carvalho M, Barata N, Evangelista T, Chicau P, Regalla M, et al. Biochemical characterization of plasma in amyotrophic lateral sclerosis: amino acid and protein composition. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 104–10
   PubMedGoogle Scholar
• Sanchez JC, Appel RD, Golaz O, Pasquali C, Ravier F, Bairoch A, et al. Inside SWISS-2DPAGE database. Electrophoresis. 1995; 16: 1131–51
   PubMed Web of Science ®Google Scholar
• Speeckaert M, Huang G, Delanghe JR, Taes YE. Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006; 372: 33–42
   PubMed Web of Science ®Google Scholar
• White P, Cooke N. The multifunctional properties and characteristics of vitamin D-binding protein. Trends Endocrinol Metab. 2000; 11: 320–7
   PubMed Web of Science ®Google Scholar
• Kofler A, Braun A, Jenkins T, Serjeantson SW, Cleve H. Characterization of mutants of the vitamin-D-binding protein/group specific component: GC aborigine (1A1) from Australian aborigines and South African blacks, and 2A9 from south Germany. Vox Sang. 1995; 68: 50–4
   PubMed Web of Science ®Google Scholar
• Nagasawa H, Uto Y, Sasaki H, Okamura N, Murakami A, Kubo S, et al. Gc protein (vitamin D-binding protein): Gc genotyping and GcMAF precursor activity. Anticancer Res. 2005; 25: 3689–95
   PubMed Web of Science ®Google Scholar
• de Carvalho M, Swash M. Can selection of rapidly progressing patients shorten clinical trials in amyotrophic lateral sclerosis?. Arch Neurol. 2006; 63: 557–60
   PubMedGoogle Scholar
• Ramstrom M, Ivonin I, Johansson A, Askmark H, Markides KE, Zubarev R, et al. Cerebrospinal fluid protein patterns in neurodegenerative disease revealed by liquid chromatography-Fourier transform ion cyclotron resonance mass spectrometry. Proteomics. 2004; 4: 4010–8
   PubMed Web of Science ®Google Scholar
• Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, et al. Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis. J Neurochem. 2005; 95: 1461–71
   PubMed Web of Science ®Google Scholar
• Pasinetti GM, Unger LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, et al. Identification of potential CSF biomarkers in ALS. Neurology. 2006; 66: 1218–22
   PubMed Web of Science ®Google Scholar
• Beuche W, Yushchenko M, Mader M, Maliszewska M, Felgenhauer K, Weber F. Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis. Neuroreport. 2000; 11: 3419–22
   PubMed Web of Science ®Google Scholar
• Neumann M, Kwong LK, Sampathu DM, Trojanowski JQ, Lee VM. TDP-43 proteinopathy in frontotemporal lobar degeneration and amyotrophic lateral sclerosis: protein misfolding diseases without amyloidosis. Arch Neurol. 2007; 64: 1388–94
   PubMed Web of Science ®Google Scholar
• Massignan T, Casoni F, Basso M, Stefanazzi P, Biasini E, Tortarolo M, et al. Proteomic analysis of spinal cord of presymptomatic amyotrophic lateral sclerosis G93A SOD1 mouse. Biochem Biophys Res Commun. 2007; 353: 719–25
   PubMed Web of Science ®Google Scholar
• Arnaud J, Constans J. Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993; 92: 183–8
   PubMed Web of Science ®Google Scholar
• Braun A, Brandhofer A, Cleve H. Interaction of the vitamin D-binding protein (group-specific component) and its ligand 25-hydroxy-vitamin D3: binding differences of the various genetic types disclosed by isoelectric focusing. Electrophoresis. 1990; 11: 478–83
   PubMed Web of Science ®Google Scholar
• Verboven C, Bogaerts I, Waelkens E, Rabijns A, van Baelen H, Bouillon R, et al. Actin-DBP: the perfect structural fit? Acta Crystallogr D Biol Crystallogr. 2003;59:263–73.
   PubMedGoogle Scholar
• Vasconcellos CA, Lind SE. Coordinated inhibition of actin-induced platelet aggregation by plasma gelsolin and vitamin D-binding protein. Blood. 1993; 82: 3648–57
   PubMed Web of Science ®Google Scholar
• Dahl B, Schiodt FV, Ott P, Wians F, Lee WM, Balko J, et al. Plasma concentration of Gc-globulin is associated with organ dysfunction and sepsis after injury. Crit Care Med. 2003; 31: 152–6
   PubMed Web of Science ®Google Scholar
• Lauridsen AL, Vestergaard P, Nexo E. Mean serum concentration of vitamin D-binding protein (Gc globulin) is related to the Gc phenotype in women. Clin Chem. 2001; 47: 753–6
   PubMed Web of Science ®Google Scholar
• Otterbein LR, Cosio C, Graceffa P, Dominguez R. Crystal structures of the vitamin D-binding protein and its complex with actin: structural basis of the actin-scavenger system. Proc Natl Acad Sci U S A. 2002; 99: 8003–8
   PubMed Web of Science ®Google Scholar
• Shimizu T, Hayashi H, Kato S, Hayashi M, Tanabe H, Oda M. Circulatory collapse and sudden death in respirator-dependent amyotrophic lateral sclerosis. J Neurol Sci. 1994; 124: 45–55
   PubMed Web of Science ®Google Scholar
• Elman LB, Siderowf A, Houseman G, Kelley M, McCluskey LF. Venous thrombosis in an ALS population over four years. Amyotroph Lateral Scler Other Motor Neuron Disord. 2005; 6: 246–9
   PubMed Web of Science ®Google Scholar
• Qureshi MM, Cudkowicz ME, Zhang H, Raynor E. Increased incidence of deep venous thrombosis in ALS. Neurology. 2007; 68: 76–7
   PubMed Web of Science ®Google Scholar
• Greco M, Chiriaco F, Del Boccio P, Tagliaferro L, Acierno R, Menegazzi P, et al. A proteomic approach for the characterization of C677T mutation of the human gene methylenetetrahydrofolate reductase. Proteomics. 2006;6:5350–61.
   PubMed Web of Science ®Google Scholar
• McGeer PL, McGeer EG. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002; 26: 459–70
   PubMed Web of Science ®Google Scholar
• Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, et al. Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue. Ann Neurol. 2004; 55: 221–35
   PubMed Web of Science ®Google Scholar
• Zhang R, Gascon R, Miller RG, Gelinas DF, Mass J, Hadlock K, et al. Evidence for systemic immune system alterations in sporadic amyotrophic lateral sclerosis (SALS). J Neuroimmunol. 2005; 159: 215–24
   PubMed Web of Science ®Google Scholar
• Goldknopf IL, Sheta EA, Bryson J, Folsom B, Wilson C, Duty J, et al. Complement C3c and related protein biomarkers in amyotrophic lateral sclerosis and Parkinson's disease. Biochem Biophys Res Commun. 2006; 342: 1034–9
   PubMed Web of Science ®Google Scholar